JW Pharma ApS: Financial statements 2019
CVR: 39330563
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
JW Pharma ApS (CVR 39330563) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -125,017 and a net result of DKK -125,020 compared with DKK -86,752 the year before. Equity in the 2019 report amounted to DKK -161,773.
- Gross Profit
- DKK -125,017
- Profit/Loss
- DKK -125,020
- Equity
- DKK -161,773
- Total Assets
- DKK 452,410
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -125 t. | -125 t. | -162 t. | - |
| 2018 | - | -85 t. | -87 t. | -37 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
JW Pharma ApS has published its interim report for the period February 12, 2018 – December 31, 2018.
About JW Pharma ApS
JW Pharma ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company has been dissolved on 27 October 2025. The company was registered under the industry Detailhandel med andre fødevarer. In 2024, the company reported a gross profit of DKK -5,857 and a net result of DKK -5,857 compared with DKK -4,637 the year before. Equity in the 2024 report amounted to DKK -147,099.